Making room for oxytocin in understanding depression

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 305-322

  McQuaid, Robyn J ^a   McInnis, Opal A ^a   Abizaid, Alfonso ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Depression; HPA axis; Inflammation; Monoamine; OXTR polymorphism; Oxytocin; Stress

Indexed keywords

ALPHA INTERFERON; ATOSIBAN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESCITALOPRAM; GLUCOCORTICOID; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; OXYTOCIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; DOPAMINE; MONOAMINE; OXYTOCIN RECEPTOR; ANTIDEPRESSANT AGENT;

ANTIDEPRESSANT ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; EARLY LIFE STRESS; ELECTROCONVULSIVE THERAPY; GENE FREQUENCY; GENE FUNCTION; HEPATITIS C; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; INTERPERSONAL STRESS; MAJOR DEPRESSION; MENTAL STRESS; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL ASPECT; SOCIAL SUPPORT; CORTICOTROPIN RELEASE; DISEASE MODEL; EMOTIONAL ATTACHMENT; EMOTIONAL STRESS; EXPERIMENTAL ANIMAL; HORMONE ACTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; OXTR GENE; PERSONAL EXPERIENCE; RECEPTOR GENE; SOCIAL BONDING; SOCIAL ISOLATION; TRUST; ANIMAL; BRAIN; DEPRESSIVE DISORDER; GENETICS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; HUMANS; OXYTOCIN; STRESS, PSYCHOLOGICAL;

EID: 84904755371     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.07.005     Document Type: Review

References (277)

1. Amico J.A., Cai H.M., Vollmer R.R. Corticosterone release in oxytocin gene deletion mice following exposure to psychogenic versus non-psychogenic stress. Neurosci. Lett. 2008, 442:262-266.
2. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J. Psychiatry Neurosci. 2009, 34:4-20.
3. Anisman H., Merali Z. Anhedonia and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 1999, 461:199-233.
4. Aragona B.J., Liu Y., Yu Y.J., Curtis J.T., Detwiler J.M., Insel T.R., et al. Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat. Neurosci. 2005, 9:133-139.
5. Arletti R., Bertolini A. Oxytocin acts as an antidepressant in two animals models of depression. Life Sci. 1987, 41:1725-1730.
6. Audet M.C., Anisman H. Interplay between pro-inflammatory cytokines and growth factors in depressive illness. Front. Cell. Neurosci. 2013, 7:68.
7. Averbeck B.B., Bobin T., Evans S., Shergill S.S. Emotion recognition and oxytocin in patients with schizophrenia. Psychol. Med. 2011, 42:259-266.
8. Averbeck B.B. Oxytocin and the salience of social cues. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9033-9034.
9. 2C, receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 1996, 73:277-280.
10. 1C receptors induce oxytocin release in the male rat. Brain Res. 1993, 611:330-332.
11. Bakermans-Kranenburg M.J., van Ijzendoorn M.H. Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc. Cogn. Affect. Neurosci. 2008, 3:128-134.
12. Bakos J., Strbak V., Paulikova H., Krajnakova L., Lestanova Z., Bacova Z. Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells. J. Mol. Neurosci. 2013, 50:462-468.
13. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J. Neurosci. 2001, 21:2546-2552.
14. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
15. Baskerville T.A., Douglas A.J. Dopamine and oxytocin interactions underlying potential contributions to behavioral disorders. CNS Neurosci. Ther. 2010, 16:e92-e123.
16. Baskerville T.A., Douglas A.J. Interactions between dopamine and oxytocin in the control of sexual behaviour. Prog. Brain Res. 2008, 170:277-290.
17. Bealer S.L., Crowley W.R. Neurotransmitter interaction in release of intranuclear oxytocin in magnocellular nuclei of the hypothalamus. Ann. N. Y. Acad. Sci. 2000, 897:182-191.
18. Bealer S.L., Crowley W.R. Noradrenergic control of central oxytocin release during lactation in rats. Am. J. Physiol. 1998, 274:E453-E458.
19. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes?. Mol. Psychiatry 2009, 14:746-754.
20. Belsky J., Bakermans-Kranenburg M.J., van IJzendoorn M.H. For better and for worse differential susceptibility to environmental influences. Curr. Dir. Psychol. Sci. 2007, 16(6):300-304.
21. Belsky J., Pluess M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol. Bull. 2009, 135:885-908.
22. Bernatova I., Rigatto K.V., Key M.P., Morris M. Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp. Physiol. 2004, 85:549-557.
23. Blier P., Ward H.E., Tremblay P., Laberge L., Hébert C., Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am. J. Psychiatry 2010, 167:281-288.
24. Bradley B., Davis T.A., Wingo A.P., Mercer K.B., Ressler K.J. Family environment and adult resilience: contributions of positive parenting and the oxytocin receptor gene. Eur. J. Psychotraumatol. 2013, 4:21659.
25. Bradley B., Westen D., Mercer K.B., Binder E.B., Jovanovic T., Crain D., et al. Association between childhood maltreatment and adult emotional dysregulation in a low-income, urban, African American sample: moderation by oxytocin receptor gene. Dev. Psychopathol. 2011, 23:439-452.
26. Bruhn T.O., Sutton S.W., Plotsky P.M., Vale W.W. Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat. Endocrinology 1986, 119:1558-1563.
27. Brüne M. Does the oxytocin receptor (OXTR) polymorphism (rs2254298) confer 'vulnerability' for psychopathology or 'differential susceptibility'? Insights from evolution. BMC Med. 2012, 10:38.
28. Brunton P.J., Russell J.A. Keeping oxytocin neurons under control during stress in pregnancy. Prog. Brain Res. 2008, 170:365-377.
29. Brunton P.J., Sabatier N., Leng G., Russell J.A. Suppressed oxytocin neuron responses to immune challenge in late pregnant rats: a role for endogenous opioids. Eur. J. Neurosci. 2006, 23:1241-1247.
30. Bülbül M., Babygirija R., Cerjak D., Yoshimoto S., Ludwig K., Takahashi T. Hypothalamic oxytocin attenuates CRF expression via GABA(A) receptors in rats. Brain Res. 2011, 1387:39-45.
31. Buller K.M., Xu Y., Day T.A. Indomethacin attenuates oxytocin and hypothalamic- pituitary-adrenal axis responses to systemic interleukin-1β. J. Neuroendocrinol. 1998, 10:519-528.
32. Burkett J.P., Young L.J. The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) 2012, 224:1-26.
33. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon alpha. Biol. Psychiatry 2004, 56:819-824.
34. Cardoso C., Ellenbogen M.A., Linnen A.M. The effect of intranasal oxytocin on perceiving and understanding emotion on the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Emotion 2014, 14:43-50.
35. Cardoso C., Linnen A.M., Joober R., Ellenbogen M.A. Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. Exp. Clin. Psychopharmacol. 2012, 20:84-91.
36. Cardoso C., Ellenbogen M.A., Orlando M.A., Bacon S.L., Joober R. Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology 2013, 38:399-407.
37. Cardoso C., Ellenbogen M.A., Serravalle L., Linnen A.M. Stress-induced negative mood moderates the relation between oxytocin administration and trust: evidence for the tend-and-befriend response to stress?. Psychoneuroendocrinology 2013, 38:2800-2804.
38. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 1998, 23:779-818.
39. Carter C.S. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?. Behav. Brain Res. 2007, 176:170-186.
40. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life-stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
41. Catena-Dell'Osso M., Fagiolini A., Marazziti D., Baroni S., Bellantuono C. Non-monoaminergic targets for the development of antidepressants: focus on neuropeptides. Mini Rev. Med. Chem. 2013, 13:2-10.
42. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
43. Chen F.S., Kumsta R., von Dawans B., Monakhov M., Ebstein R.P., Heinrichs M. Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19937-19942.
44. Chiodera P., Coiro V. Oxytocin reduces metyrapone-induced ACTH secretion in human subjects. Brain Res. 1987, 420:178-181.
45. Choleris E., Devidze N., Kavaliers M., Pfaff D.W. Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety. Prog. Brain Res. 2008, 170:291-303.
46. Clodi M., Vila G., Geyeregger R., Riedl M., Stulnig T.M., Struck J., et al. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E686-E691.
47. Cohen H., Kaplan Z., Kozlovsky N., Gidron Y., Matar M.A., Zohar J. Hippocampal microfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. J. Neuroendocrinol. 2010, 22:889-904.
48. Coiro V., Passeri M., Davoli C., Bacchi-Modena A., Bianconi L., Volpi R., et al. Oxytocin reduces exercise-induced ACTH and cortisol rise in man. Acta Endocrinol. (Copenh.) 1988, 119:405-412.
49. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
50. Corwin E.J., Johnston N., Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol. Res. Nurs. 2008, 10:128-133.
51. Costa B., Pini S., Gabelloni P., Abelli M., Lari L., Cardini A., et al. Oxytocin receptor polymorphisms and adult attachment style in patients with depression. Psychoneuroendocrinology 2009, 34:1506-1514.
52. Crowley W.R., Armstrong W.E. Neurochemical regulation of oxytocin secretion in lactation. Endocr. Rev. 1992, 13:33-65.
53. Cruwys T., Dingle G.A., Haslam C., Haslam A.S., Jetten J., Morton T.A. Social group memberships protect against future depression, alleviate depression symptoms and prevent depression relapse. Soc. Sci. Med. 2013, 98:179-186.
54. Cunningham E.T., Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 1988, 274:60-76.
55. Cyranowski J.M., Hofkens T.L., Frank E., Seltman H., Cai H.M., Amico J.A. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom. Med. 2008, 70:967-975.
56. Danevova V., Kvetnansky R., Jezova D. Kinetics of oxytocin response to repeated restraint stress and/or chronic cold exposure. Horm. Metab. Res. 2013, 45:845-848.
57. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
58. Dantzer R., O'Conner J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
59. De Dreu C.K., Greer L.L., Handgraaf M.J., Shalvi S., Van Kleef G.A., Baas M., et al. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 2010, 328:1408-1411.
60. De Dreu C.K., Greer L.L., Van Kleef G.A., Shalvi S., Handgraaf M.J. Oxytocin promotes human ethnocentrism. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1262-1266.
61. de Jong T.R., Veening J.G., Olivier B., Waldinger M.D. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J. Sex. Med. 2007, 4:14-28.
62. de Oliveira D.C., Zuardi A.W., Graeff F.G., Queiroz R.H., Crippa J.A. Anxiolytic-like effect of oxytocin in the simulated public speaking test. J. Psychopharmacol. 2011, 26:497-504.
63. Depue R.A., Morrone-Strupinsky J.V. A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation. Behav. Brain Sci. 2005, 28:313-350.
64. Deschamps S., Woodside B., Walker C.D. Pups presence eliminates the stress hyporesponsiveness of early lactating females to a psychological stress representing a threat to the pups. J. Neuroendocrinol. 2003, 15:486-497.
65. Detillion C.E., Craft T.K., Glasper E.R., Prendergast B.J., DeVries A.C. Social facilitation of wound healing. Psychoneuroendocrinology 2004, 29:1004-1011.
66. Devanand D.P., Lisanby S., Lo E.S., Fitzsimons L., Cooper T.B., Halbreich U., et al. Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. Biol. Psychiatry 1998, 44:610-616.
67. Ditzen B., Neumann I.D., Bodenmann G., von Dawans B., Turner R.A., Ehlert U., et al. Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women. Psychoneuroendocrinology 2007, 32:565-574.
68. Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol. Psychiatry 2009, 65:728-731.
69. Dluzen D.E., Muraoka S., Landgraf R. Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses. Neurosci. Lett. 1998, 254:161-164.
70. Dube S.R., Anda R.F., Felitti V.J., Chapman D.P., Williamson D.F., Giles W.H. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA 2001, 286:3089-3096.
71. Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012, 338:68-72.
72. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54:597-606.
73. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007, 34:865-877.
74. D'Sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord. 2002, 4:183-194.
75. Eaton J.L., Roache L., Nguyen K.N., Cushing B.S., Troyer E., Papademetriou E., et al. Organizational effects of oxytocin on serotonin innervation. Dev. Psychobiol. 2012, 54:92-97.
76. Ellenbogen M.A., Linnen A.-M., Cardoso C., Joober R. Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology 2013, 38:387-398.
77. Ellenbogen M.A., Linnen A.-M., Grumet R., Cardoso C., Joober R. The acute effects of intranasal oxytocin on automatic and effortful attention shifting to emotional faces. Psychophysiology 2012, 49:128-137.
78. Emiliano A.B.F., Cruz T., Pannoni V., Fudge J.L. The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus a substrate for SSRIs therapeutic effects?. Neuropsychopharmacology 2007, 32:977-988.
79. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15506-15511.
80. Feifel D., Macdonald K., Cobb P., Minassian A. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophr. Res. 2012, 139:207-210.
81. Feldman R., Zagoory-Sharon O., Weisman O., Schneiderman I., Gordon I., Maoz R., et al. Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes. Biol. Psychiatry 2012, 72:175-181.
82. Felitti V.J., Anda R.F., Nordenberg D., Williamson D.F., Spitz A.M., Edwards V., et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am. J. Prev. Med. 1998, 14:245-258.
83. Flak J.N., Jankord R., Solomon M.B., Krause E.G., Herman J.P. Opposing effects of chronic stress and weight restriction on cardiovascular, neuroendocrine and metabolic function. Physiol. Behav. 2011, 104:228-234.
84. Frasch A., Zetzsche T., Steiger A., Jirikowski G.F. Reduction of plasma oxytocin levels in patients suffering from major depression. Adv. Exp. Med. Biol. 1995, 395:257-258.
85. Frasure-Smith N., Lespérance F., Irwin M.R., Talajic M., Pollock B.G. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav. Immun. 2009, 23:1140-1147.
86. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofleld P.R., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol. Psychiatry 2009, 14:681-695.
87. Gaughran F., Payne J., Sedgwick P.M., Cotter D., Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res. Bull. 2006, 70:221-227.
88. Gingrich B., Liu Y., Cascio C., Wang Z., Insel T.R. Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster). Behav. Neurosci. 2000, 114:173-183.
89. Gordon I., Zagoory-Sharon O., Schneiderman I., Leckman J.F., Weller A., Feldman R. Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress. Psychophysiology 2008, 45:349-352.
90. Gouin J.P., Carter S.C., Pournajafi-Nazarloo H., Glaser R., Marlarkey W.B., Loving T.J., et al. Marital behavior, oxytocin, vasopressin, and wound healing. Psychoneuroendocrinology 2010, 35:1082-1090.
91. Grippo A.J., Trahanas D.M., Zimmerman R.R., Porges S.W., Carter C.S. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 2009, 34:1542-1553.
92. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
93. Guastella A.J., Mitchell P.B., Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol. Psychiatry 2008, 64:256-258.
94. Gutkowska J., Jankowski M. Oxytocin revisited: it is also a cardiovascular hormone. J. Am. Soc. Hypertens. 2008, 2:318-325.
95. Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H.H., McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:11704-11709.
96. Guzmán Y.F., Tronson N.C., Jovasevic V., Sato K., Guedea A.L., Mizukami H., et al. Fear-enhancing effects of septal oxytocin receptors. Nat. Neurosci. 2013, 16:1185-1187.
97. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
98. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulated activity and mesolimbic connectivity. Biol. Psychiatry 2009, 66:407-414.
99. Hashiguchi H., Ye S.H., Morris M., Alexander N. Single and repeated environmental stress: effect on plasma oxytocin, corticosterone, catecholamines and behavior. Physiol. Behav. 1997, 61:731-736.
100. Heim C., Newport J.D., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710.
101. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol. Psychiatry 2008, 14:954-958.
102. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
103. Heinrichs M., Domes G. Neuropeptides and social behavior: effects of oxytocin and vasopressin in humans. Prog. Brain Res. 2008, 170:337-350.
104. Herbison A.E., Voisin D.L., Douglas A.J., Chapman C. Profile of monoamine and excitatory amino acid release in rat supraoptic nucleus over parturition. Endocrinology 1997, 138:33-40.
105. Ho S.S., Chow B.K., Yung W.H. Serotonin increases the excitability of the hypothalamic parventricular nucleus magnocellular neurons. Eur. J. Neurosci. 2007, 25:2991-3000.
106. Hodges S.D., Kline K. Regulating the costs of empathy: the price of being human. J. Socio-Econ. 2001, 30:437-452.
107. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., et al. Oxytocin infusion reduces repetitive behaviours in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003, 28:193-198.
108. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., et al. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 2007, 61:498-503.
109. Holt-Lunstad J., Birmingham W., Light K.C. The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention. Psychoneuroendocrinology 2011, 36:1249-1256.
110. Insel T.R., Hulihan T.J. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav. Neurosci. 1995, 109:782-789.
111. Insel T.R. Is social attachment an addictive disorder?. Physiol. Behav. 2003, 79:351-357.
112. Insel T.R., Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5981-5985.
113. Insel T.R., Winslow J.T. Central oxytocin administration modulates rat pup ultrasonic isolation call. Eur. J. Pharmacol. 1991, 203:149-152.
114. Insel T.R., Young L.S. The neurobiology of attachment. Nat. Rev. Neurosci. 2001, 2:129-136.
115. İşeri S.O., Şener G., Saǧlam B., Gedik N., Ercan F., Yeǧen B.C. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J. Surg. Res. 2005, 126:73-81.
116. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol. 2010, 105:205-218.
117. Jin D., Liu H.X., Hirai H., Torashima T., Nagai T., Lopatina O., et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007, 446:41-45.
118. Jørgensen H., Kjaer A., Knigge U., Møller M., Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J. Neuroendocrinol. 2003, 15:564-571.
119. Kamm K., Vanderkolk W., Lawrence C., Jonker M., Davis A.T. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J. Trauma 2006, 60:152-157.
120. Kasting N.W. Indomethacin, an antipyretic drug, prevents the endotoxin-induced and potentiates the hemorrhage-induced oxytocin release into the plasma of the male rat. Neuroendocrinology 1986, 42:285-288.
121. Kawamura Y., Liu X., Akiyama T., Shimada T., Otowa T., Sakai Y., et al. The association between oxytocin receptor gene (OXTR) polymorphisms and affective temperaments, as measured by TEMPS-A. J. Affect. Disord. 2010, 127:31-37.
122. Keating C., Dawood T., Barton D.A., Lambert G.W., Tilbrook A.J. Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder. BMC Psychiatry 2013, 13:124.
123. Keck M.E., Welt T., Müller M.B., Landgraf R., Holsboer F. The high-affinity non- peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 2003, 36:27-31.
124. Kempermann G., Kronenberg G. Depressed new neurons--adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 2003, 54:499-503.
125. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 1993, 29:85-96.
126. Kim H.S., Sherman D.K., Sasaki J.Y., Xu J., Chu T.Q., Ryu C., et al. Culture, distress and oxytocin receptor polymorphism (OXTR) interact to influence emotional support seeking. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15717-15721.
127. Kimura T. Investigation of the oxytocin receptor at the molecular level. Oxytocin: Cellular and Molecular Approaches in Medicine and Research 1995, 259. Plenum Press, New York. R. Ivell, J.A. Russell (Eds.).
128. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 7:11489-11493.
129. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
130. Kovács G.L., Sarnyai Z., Szabó G. Oxytocin and addiction: a review. Psychoneuroendocrinology 1998, 23:945-962.
131. Kraemer G.W. A psychobiological theory of attachment. Behav. Brain Sci. 1992, 15:493-541.
132. Krueger F., Parasuraman R., Iyengar V., Thornburg M., Weel J., Lin M., et al. Oxytocin receptor genetic variation promotes human trust behavior. Front. Hum. Neurosci. 2012, 6:4.
133. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 2002, 1:S71-S80.
134. Labuschagne I., Phan K.L., Wood A., Angstadt M., Chua P., Heinrichs M., et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413.
135. Landgraf R., Neumann I., Holsboer F., Pittman Q.J. Interleukin-1β stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur. J. Neurosci. 1995, 7:592-598.
136. Lane A., Luminet O., Rimé B., Gross J.J., de Timary P., Mikolajczak M. Oxytocin increases willingness to socially share one's emotions. Int. J. Psychol. 2013, 48:676-681.
137. Lazarus R.S. The role of coping in the emotions and how coping changes over the life course. Handbook of Emotion, Adult Development, and Aging 1996, 289-306.
138. Ledeboer A., Binnekade R., Brevé J.J., Bol J.G., Tilders F.J., Van Dam A.M. Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R1762-R1772.
139. Lee R., Garcia F., van de Kar L.D., Hauger R.D., Coccaro E.F. Plasma oxytocin response to pharmaco-challenge to d-fenfluramine and placebo in healthy men. Psychiatry Res. 2003, 118:129-136.
140. Legros J.J., Chiodera P., Geenen V., Smitz S., von Frenckell R. Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men. J. Clin. Endocrinol. Metab. 1984, 58:105-109.
141. Legros J.J., Chiodera P., Geenen V., von Frenckell R. Confirmation of the inhibitory influence of exogenous oxytocin on cortisol and ACTH in man: evidence of reproducibility. Acta Endocrinol. (Copenh.) 1987, 114:345-349.
142. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
143. Leuner B., Caponiti J.M., Gould E. Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids. Hippocampus 2012, 22:861-868.
144. Lévy F., Guevara-Guzman R., Hinton M.R., Kendrick K.M., Keverne E.B. Effects of parturition and maternal experience on noradrenaline and acetylcholine release in the olfactory bulb of sheep. Behav. Neurosci. 1993, 107:662-668.
145. Lewis D.A., Sherman B.M. Oxytocin does not influence adrenocorticotropin secretion in man. J. Clin. Endocrinol. Metab. 1985, 60:53-56.
146. Li Q., Levy A.D., Cabrera T.M., Brownfield M.S., Battaglia G., Van de Kar L.D. Long-term fluoxetine, but not desipramine, inhibits the ACTH oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res. 1993, 630:148-156.
147. Linnen A.-M., Ellenbogen M.A., Cardoso C., Joober R. Intranasal oxytocin and salivary cortisol concentrations during social rejection in university students. Stress 2012, 15:393-402.
148. Litvin Y., Murakami G., Pfaff D.W. Effects of chronic social defeat on behavioral and neural correlated on sociality: vasopressin, oxytocin and the vasopressinergic V1b receptor. Physiol. Behav. 2011, 103:393-403.
149. Liu Y., Wang X. Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003, 121:537-544.
150. Love T.M., Enoch M.-A., Hodgkinson C.A., Pecina M., Mickey B., Koeppe R.A. Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol. Psychiatry 2012, 72:198-206.
151. Love T.M. Oxytocin, motivation and the role of dopamine. Pharmacol. Biochem. Behav. 2014, 119C:49-60.
152. Lucht M.J., Barnow S., Sonnenfeld C., Rosenberger A., Grabe H.J., Schroeder W., et al. Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:860-866.
153. MacDonald K., MacDonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
154. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995, 19:11-38.
155. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:664-675.
156. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:702-721.
157. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Psychopharmacology: The Fourth Generation of Progress 1995, 933-934. Raven Press, New York.
158. Mahar I., Bambico F.R., Mechawar N., Nobrega J.N. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci. Biobehav. Rev. 2014, 38:173-182.
159. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 1998, 105:83-107.
160. MacLean P.D. The Triune Brain in Evolution: Role in Paleocerebral Functions 1990, Plenum Press, New York.
161. MacLeod C., Mathews A., Tata P. Attentional bias in emotional disorders. J. Abnorm. Psychol. 1986, 95:15-20.
162. Mantella R.C., Vollmer R.R., Rinaman L., Li X., Amico J.A. Enhanced corticosterone concentrations and attenuated Fos expression in the medial amygdala of female oxytocin knockout mice exposed to psychogenic stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R1494-R1504.
163. Marazziti D., Baroni S., Giannaccini G., Betti L., Massimetti G., Carmassi C., Catena-Dell'Osso M. A link between oxytocin and serotonin in humans: supporting evidence from peripheral markers. Eur. Neuropsychopharmacol. 2012, 22:578-583.
164. Marazziti D., Catena-DellOsso C.M. The role of oxytocin in neuropsychiatric disorders. Curr. Med. Chem. 2008, 15:698-704.
165. Matheson K., Anisman H. Systems of coping associated with dysphoria, anxiety and depressive illness: a multivariate profile perspective. Stress 2003, 6:223-234.
166. Matsushita H., Matsuzaki M., Han X.-J., Nishiki T.-I., Ohmori I., Michiue H., et al. Antidepressant-like effect of sildenafil through oxytocin-dependent cyclic amp response element-binding protein phosphorylation. Neuroscience 2012, 200:13-18.
167. Matsuzaki M., Matsushita H., Tomizawa K., Matsui H. Oxytocin: a therapeutic target for mental disorders. J. Physiol. Sci. 2012, 62:441-444.
168. McCullough M.E., Churchland P.S., Mendez A.J. Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?. Neurosci. Biobehav. Rev. 2013, 37:1485-1492.
169. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999, 22:105-122.
170. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
171. McQuaid R.J., McInnis O.A., Stead J.D., Matheson K., Anisman H. The paradoxical association of the oxytocin receptor gene polymorphism: early-life adversity and vulnerability to depression. Front. Neurosci. 2013, 7:128.
172. Meisenberg G. Short-term behavioral effects of neurohypophyseal peptides in mice. Peptides 1981, 2:1-8.
173. Meinlschmidt G., Heim C. Sensitivity to intranasal oxytocin in adult men with early parental separation. Biol. Psychiatry 2007, 61:1109-1111.
174. Melis M.R., Melis T., Cocco C., Succu S., Sanna F., Pillolla G., et al. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats. Eur. J. Neurosci. 2007, 26:1026-1035.
175. Melis M.R., Succu S., Sanna F., Boi A., Argiolas A. Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats. Eur. J. Neurosci. 2009, 30:1349-1357.
176. Mendlewicz J., Crisafulli C., Calati R., Kocabas N.A., Massat I., Linotte S., et al. Influence of COX-3 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neurosci. Lett. 2012, 516:85-88.
177. Meynen G., Unmehopal U.A., Hofman M.A., Swaab D.F., Hoogendijk W.J.G. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol. Psychiatry 2007, 12:118-119.
178. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 2006, 110:135-370.
179. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents; the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
180. Miyahara S., Komori T., Fujiwara R., Shizuya K., Yamamoto M., Ohmori M., et al. Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci. 2000, 66:PL93-PL98.
181. Mogenson G.J., Yang C.R. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv. Exp. Med. Biol. 1991, 295:267-290.
182. Mohiyeddini C., Opacka-Juffry J., Gross J.J. Emotional suppression explains the link between early life stress and plasma oxytocin. Anxiety Stress Coping 2014, [Epub Ahead of Print].
183. Montag C., Flebach C.J., Kirsch P., Reuter M. Interactions of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. Biol. Psychiatry 2011, 69:601-603.
184. Mottolese R., Redouté J., Costes N., Le Bars D., Sirigu A. Switching brain serotonin with oxytocin. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(23):8637-8642.
185. Muir J.L., Pfister H.P. Influence of exogenously administered oxytocin on the corticosterone and prolactin responses to psychological stress. Pharmacol. Biochem. Behav. 1988, 29:699-703.
186. Müller M.B., Landgraf R., Preil J., Sillaber I., Kresse A.E., Keck M.E., et al. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 2000, 141:4262-4269.
187. Nadeau S., Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999, 93:1449-1464.
188. Naito Y., Fukata J., Shindo K., Ebisui O., Murakami N., Tominaga T., et al. Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats. Biochem. Biophys. Res. Commun. 1991, 174:1189-1195.
189. -/- mice. Psychosom. Med. 2010, 72:376-382.
190. Nelson E.E., Panksepp J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. Neurosci. Biobehav. Rev. 1998, 22:437-452.
191. Nelson R.J., Trainor B.C. Neural mechanisms of aggression. Nat. Rev. Neurosci. 2007, 8:536-546.
192. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
193. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
194. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J. Neuroendocrinol. 2008, 20:858-865.
195. Neumann I.D., Torner L., Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behavior in virgin, pregnant and lactating rats. Neuroscience 2000, 95:567-575.
196. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 1998, 18:2239-2246.
197. Nomura M., Saito J., Ueta Y., Muglia L.J., Pfaff D.W., Ogawa S. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice. J. Neuroendocrinol. 2003, 15:1054-1061.
198. Norman G.J., Hawkley L., Luhmann M., Ball A.B., Cole S.W., Berntson G.C., et al. Variation in the oxytocin receptor gene influences neurocardiac reactivity to social stress and HPA function: a population based study. Horm. Behav. 2012, 61:134-139.
199. Norman G.J., Karelina K., Morris J.S., Zhang N., Cochran M., DeVries C.A. Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom. Med. 2010, 72:519-526.
200. Northoff G., Walter M., Schulte R.F., Beck J., Dydak U., Henning A., et al. GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat. Neurosci. 2007, 10:1515-1517.
201. O'Connor L.E., Berry J.W., Weiss J., Gilbert P. Guilt, fear, submission, and empathy in depression. J. Affect. Disord. 2002, 71:19-27.
202. Olff M. Bonding after trauma: on the role of social support and the oxytocin system in traumatic stress. Eur. J. Psychotraumatol. 2012, 3:18597.
203. Oliveira-Pelegrin G.R., Saia R.S., Cárnio E.C., Rocha M.J. Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages. Neuroimmunomodulation 2013, 20:65-71.
204. Onaka T., Ikeda K., Yamashita T., Honda K. Facilitative role of endogenous oxytocin in noradrenaline release in the rat supraoptic nucleus. Eur. J. Neurosci. 2003, 18:3018-3026.
205. Opacka-Juffry J., Mohiyeddini C. Experience of stress in childhood negatively correlates with plasma oxytocin concentration in adult men. Stress 2012, 15:1-10.
206. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res. 2009, 169:249-252.
207. Parker K.J., Buckmaster C.L., Schatzberg A.F., Lyons D.M. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology 2005, 30:924-929.
208. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., et al. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res. 2010, 178:359-362.
209. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., et al. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr. Res. 2011, 132:50-53.
210. Petersson M., Hulting A.-L., Uvnäs-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci. Lett. 1999, 264:41-44.
211. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
212. Pierrehumbert B., Torrisi R., Ansermet F., Borghini A., Halfon O. Adult attachment representations predict cortisol and oxytocin responses to stress. Attach. Hum. Dev. 2012, 14:453-576.
213. Pierrehumbert B., Torrisi R., Laufer D., Halfon O., Ansermet F., Popovic B.M. Oxytocin response to an experimental psychosocial challenge in adults exposed to traumatic experiences during childhood or adolescence. Neuroscience 2010, 166:168-177.
214. Pigott H.E., Leventhal A.M., Alter G.S., Boren J.J. Efficacy and effectiveness of antidepressants: current status of research. Psychother. Psychosom. 2010, 79:267-279.
215. Pincus D., Kose S., Arana A., Johnson K., Morgan P.S., Borckardt J., et al. Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled fMRI study. Front. Psychiatry 2010, 1:134.
216. Purba J.S., Hoogendijk W.J., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 1996, 53:137-143.
217. Quirin M., Kuhl J., Düsing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology 2011, 36:898-904.
218. Rault J.-L., Carter C.S., Garner J.P., Marchant-Forde J.N., Richert B.T., Lay D.C. Repeated intranasal oxytocin administration in early life dysregulates the HPA axis and alters social behavior. Physiol. Behav. 2013, 112-113:40-48.
219. Ravindran A.V., Griffiths J., Waddell C., Anisman H. Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995, 19:637-653.
220. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000, 12:2-19.
221. Roberts J.E., Gotlib I.H., Kassel J.D. Adult attachment security and symptoms of depression: the mediating roles of dysfunctional attitudes and low self-esteem. J. Pers. Soc. Psychol. 1996, 70:310-320.
222. Rodrigues S.M., Saslow L.R., Garcia N., John O.P., Keltner D. Oxytocin receptor genetic variation related to empathy and stress reactivity in humans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21437-21441.
223. Romero-Fernandez W., Borroto-Escuela D.O., Agnati L.F., Fuxe K. Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor-receptor interactions. Mol. Psychiatry 2013, 18:849-850.
224. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
225. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
226. Saphire-Bernstein S., Way B.M., Kim H.S., Sherman D.K., Taylor S.E. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15118-15122.
227. Sapolsky R.M., Plotsky P.M. Hypercortisolism and its possible neural bases. Biol. Psychiatry 1990, 27:937-952.
228. Sasayama D., Hattori K., Teraishi T., Hori H., Ota M., Yoshida S., et al. Negative correlation between cerebrospinal fluid oxytocin and negative symptoms of male patients with schizophrenia. Schizophr. Res. 2012, 139:201-206.
229. Sauer C., Montag C., Reuter M., Kirsch P. Imaging oxytocin×dopamine interactions: an epistais effect of CD38 and COMT gene variants influences the impact of oxytocin on amygdala activation to social stimuli. Front. Neurosci. 2013, 7:45.
230. Sawchenko P.E., Swanson L.W., Steinbusch H.W.M., Verhofstad A.A.J. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 1983, 277:355-360.
231. Saydoff J.A., Rittenhouse P.A., van de Kar L.D., Brownfield M.S. Enhanced serotonergic transmission stimulates oxytocin secretion in the conscious male rats. J. Pharmacol Exp. Ther. 1991, 257:95-99.
232. Scantamburlo G., Ansseau M., Geenen V., Legros J.-J. Intranasal oxytocin as an adjunct to escitalopram in major depression. J. Neuropsychiatry Clin. Neurosci. 2011, 23:E5.
233. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Maréchal P., Pequeux C., et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 2007, 32:407-410.
234. Scott A.I., Whalley L.J., Bennie J., Bowler G. Oestrogen stimulated neurophysin and outcome after electroconvulsive therapy. Lancet 1986, 1:1411-1414.
235. Scott A.I., Whalley L.J., Legros J.J. Treatment outcome, seizure duration, and the neurophysin response to ECT. Biol. Psychiatry 1989, 25:585-597.
236. Seltzer L.J., Ziegler T.E., Pollak S.D. Social vocalizations can release oxytocin in humans. Proc. Biol. Sci. 2010, 277:2661-2666.
237. Shahrokh D.K., Zhang T.Y., Diorio J., Gratton A., Meaney M.J. Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010, 151:2276-2286.
238. Shapiro L.E., Insel T.R. Infant's response to social separation reflects adult differences in affiliative behavior: a comparative developmental study in prairie and montane voles. Dev. Psychobiol. 1990, 23:375-394.
239. Siegel G.J., Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 2000, 33:119-227.
240. Simeon D., Bartz J., Hamilton H., Crystal S., Braun A., Ketay S., et al. Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology 2011, 36:1418-1421.
241. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
242. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
243. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J. 2006, 20:670-682.
244. Strauss J.S., Freeman N.L., Shaikh S.A., Vetro A., Kiss E., Kapornai K., et al. No association between oxytocin or prolactin gene variants and childhood-onset mood disorders. Psychoneuroendocrinology 2010, 35:1422-1428.
245. Striepens N., Kendrick K.M., Hanking V., Landgraf R., Wüllner U., Maier W., et al. Elevated cerebrosprinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 2013, 3:3440.
246. Szeto A., Nation D.A., Mendez A.J., Dominguez-Bendala J., Brooks L.G., Schneidermann N., et al. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1495-E1501.
247. Szeto A., Rossetti M.A., Mendez A.J., Noller C.M., Herderick E.E., Gonzales J.A., et al. Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits. Psychoneuroendocrinology 2013, 38:685-693.
248. Tabak B.A., McCullough M.E., Szeto A., Mendez A.J., McCabe P.M. Oxytocin indexes relational distress following interpersonal harms in women. Psychoneuroendocrinology 2011, 36:115-122.
249. Taylor S.E., Gonzaga G.C., Klein L.C., Hu P., Greendale G.A., Seeman T.E. Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosom. Med. 2006, 68:238-245.
250. Taylor S.E., Saphire-Bernstein S., Seeman T.E. Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?. Psychol. Sci. 2010, 21:3-7.
251. Taylor S.E. Tend and befriend biobehavioral bases of affiliation under stress. Curr. Dir. Psychol. Sci. 2006, 15:273-277.
252. Thompson R.J., Parker K.J., Hallmayer J.F., Waugh C.E., Gotlib I.H. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011, 36:144-147.
253. Tomizawa K., Iga N., Lu Y.F., Moriwaki A., Matsushita M., Li S.T., et al. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat. Neurosci. 2003, 6:384-390.
254. Tops M., Buisman-Pijlman F.T., Boksem M.A., Wijers A.A., Korf J. Cortisol-induced increases of plasma oxytocin levels predict decreased immediate free recall of unpleasant words. Front. Psychiatry 2012, 3:43.
255. Tops M., Riese H., Oldehinkel A.J., Rijsdijk F.V., Ormel J. Rejection sensitivity relations to hypocortisolism and depressed mood state in young women. Psychoneuroendocrinology 2008, 33:551-559.
256. Tops M., van Peer J.M., Wester A.E., Wijers A.A., Korf J. State-dependent regulation of cortical activity by cortisol: an EEG study. Neurosci. Lett. 2006, 404:39-43.
257. Uvnäs-Moberg K., Bjökstrand E., Hillegaart V., Ahlenius S. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl) 1999, 142:95-101.
258. Vacher C.M., Fretier P., Creminon C., Calas A., Hardin-Pouzet H. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J. Neurosci. 2002, 22:1513-1522.
259. Van de Kar L.D., Rittenhouse P.A., Li Q., Levy A.D., Brownfield M.S. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res. Bull. 1995, 36:45-50.
260. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997, 17:284-292.
261. van Roekel E., Verhagen M., Engels R.C., Goossens L., Scholte R.H. Oxytocin receptor gene (OXTR) in relation to loneliness in adolescence: interactions with sex, parental support and DRD2 and 5-HTTLPR genotypes. Psychiatr. Genet. 2013, 23:204-213.
262. Veinante P., Freund-Mercier M.J. Distribution of oxytocin-and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J. Comp. Neurol. 1997, 383:305-325.
263. Walker C.D., Deschamps S., Proulx K., Tu M., Salzman C., Woodside B., et al. Mother to infant or infant mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans. J. Psychiatry Neurosci. 2004, 29:364-382.
264. Walker C.-D., Lightman S.L., Steele M.K., Dallman M.F. Suckling is a persistent stimulus to the adrenocortical system of the rat. Endocrinology 1992, 130:115-125.
265. Wang Z., Yu G., Cascio C., Liu Y., Gingrich B., Insel T.R. Dopamine D2 receptor-mediated regulation of partner preferences in female prairie voles (Microtus ochrogaster): a mechanism for pair bonding?. Behav. Neurosci. 1999, 113:602-611.
266. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
267. Windle R.J., Kershaw Y.M., Shanks N., Wood S.A., Lightman S.L., Ingram C.D. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J. Neurosci. 2004, 24:2974-2982.
268. Yayou K., Ito S., Kasuya E., Sutoh M., Ohkura S., Okamura H. Intracerebroventricularly administered oxytocin attenuated cortisol secretion, but not behavioral responses, during isolation in Holstein steers. J. Vet. Med. Sci. 2008, 70:665-671.
269. Yehuda R., Southwick S.M., Nussbaum G., Wahby V., Giller, Mason J.W. Low urinary cortisol excretion in patients with posttraumatic stress disorder. J. Nerv. Ment. Dis. 1990, 178:366-369.
270. Yoshida M., Takayanagi Y., Inoue K., Kimura T., Young L.J., Onaka T., et al. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 2009, 29:2259-2271.
271. Young L.J., Lim M.M., Gingrich B., Insel T.R. Cellular mechanisms of social attachment. Horm. Behav. 2001, 40:133-138.
272. Young L.J., Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004, 7:1048-1054.
273. Yuen K.W., Garner J.P., Carson D.S., Keller J., Lembke A., Hyde S.A., et al. Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. J. Psychiatr. Res. 2014, 51:30-36.
274. Zetzsche T., Frasch A., Jirikowski G., Murck H., Steiger A. Nocturnal oxytocin secretion is reduced in major depression. Biol. Psychiatry 1996, 39:584.
275. Zheng J., Babygirija R., Bülbül M., Cerjak D., Ludwig K., Takahashi T. Hypothalamic oxytocin mediates adaptation mechanism against chronic stress in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G946-G953.
276. Zhu L., Onaka T. Involvement of medullary A2 noradrenergic neurons in the activation of oxytocin neurons after conditioned fear stimuli. Eur. J. Neurosci. 2002, 16:2186-2198.
277. Zhu Y., Saito K., Murakami Y., Asano M., Iwakura Y., Seishima M. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia. Neurosci. Lett. 2006, 393:122-126.